Volume | 8,897,117 |
|
|||||
News | - | ||||||
Day High | 9.53 | Low High |
|||||
Day Low | 9.08 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
Advisorshares Pure Us Cannabis Etf | MSOS | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
9.50 | 9.08 | 9.53 | 9.25 | 9.52 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
25,074 | 8,897,117 | 9.34 | 83,082,131 | - | 4.78 - 10.955 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
17:42:03 | formt | 500 | 9.15 | USD |
Advisorshares Pure Us Ca... (MSOS) Options Flow Summary
Advisorshares Pure Us Cannabis Etf Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.05B | - | - | - | 12.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Advisorshares Pure Us Ca...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MSOS Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.73 | 9.92 | 8.5541 | 9.21 | 10,523,508 | -0.58 | -5.96% |
1 Month | 9.08 | 10.955 | 8.5541 | 9.70 | 10,812,597 | 0.07 | 0.77% |
3 Months | 9.02 | 10.955 | 7.30 | 9.29 | 8,549,769 | 0.13 | 1.44% |
6 Months | 7.26 | 10.955 | 4.92 | 8.21 | 7,274,723 | 1.89 | 26.03% |
1 Year | 5.54 | 10.955 | 4.78 | 7.70 | 5,924,598 | 3.61 | 65.16% |
3 Years | 40.15 | 44.14 | 4.78 | 10.77 | 2,936,686 | -31.00 | -77.21% |
5 Years | 24.90 | 55.91 | 4.78 | 12.18 | 2,536,383 | -15.75 | -63.25% |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified. |